Switch maintenance gemcitabine after first-line chemotherapy in patients with malignant mesothelioma: A multicenter open label phase II trial (NVALT19)
Authors:
- S.A. BurgersSBS.A. Burgers
- H.J.M. GroenHGH.J.M. Groen
Open Access
- 1 October 2019
- journal article
- research article
- Published by Elsevier in Annals of Oncology
- Vol. 30 (Supplement) , v931-v932